AxoGen, Inc. Makes First Commercial Shipment of Avance


Alachua, FL (PRWEB) July 16, 2012

AxoGen, Inc. (OTCBB:AXGN), a leading regenerative medicine company focused on the development and commercialization of products and technologies for peripheral nerve reconstruction and regeneration, today announced approval by the Rizzoli Orthopaedic Institute of its first commercial shipment of Avance